Newsletter Signup | Join Community
A Global Phase 3 Study Investigating Cancer Stemness Inhibitor Napabucasin was stopped due to poor results
mFOLFIRINOX improves the treatment of early stage surgically treated and advanced stage pancreatic cancer.
PARP Inhibitors Shows Promise as Treatment for Pancreatic Cancer
Treatment is with precision medicines & chemotherapy - genomic biomarker testing should be performed in all patients.
Stage III pancreatic cancer is treated with surgery, chemotherapy, or participation is a clinical trial.
ASCO 2019: PARP Inhibitors Benefit People with Pancreatic Cancer Who Have a BRCA Mutation
New pancreatic cancer treatments to be revealed at this ASCO this year.
Solid pseudopapillary neoplasm of the pancreas: Very rare and is info because someone asked:…
Real Time Genetic Sequencing Can Determine Pancreatic Cancer Treatment: …
Could there finally be a test to detect early stage pancreatic cancer? …
looking for promising clinical trials for pancreatic cancer that cant be treated by surgery?
I didnt know diabetes was associated with pancreatic cancer? Have others experienced this?…